Overview
Study information
| Network: | MHRP |
| Grant Affiliation: | NA |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Phase I/II |
| Species: | Human |
| Stage: | In Progress |
| Study Start Date: | 2011-10-01 |
| Study Made Public: | NA |
Title
Randomized, Double Blind Evaluation of Late Boost Strategies for HIV-uninfected Participants in the HIV Vaccine Efficacy Trial RV 144: Aventis Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming with VaxGen gp120 B/E (AIDSVAX® B/E) Boosting in HIV-uninfected Thai Adults
Description
RV305 is a clinical trial using ALVAC-HIV (vCP1521) and AIDSVAX® B/E to boost HIV-uninfected volunteers vaccine recipients from the RV144 Thai trial.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.